Formation, Signaling and Occurrence of Specialized Pro-Resolving Lipid Mediators—What is the Evidence so far?
Nils Helge Schebb(University of Wuppertal), Dieter Steinhilber(Goethe University Frankfurt), Katharina M. Rund(University of Wuppertal), Robert C. Murphy(University of Colorado Health), Cláes Dahlgren(University of Gothenburg), Nadine Rohwer(Universitätsklinikum Brandenburg an der Havel), Nicolas Flamand(Natural Sciences and Engineering Research Council of Canada), Valerie B. O’Donnell(Cardiff University), Mohamad Wessam Alnouri(Max Planck Institute for Heart and Lung Research), Hartmut Kühn(Charité - Universitätsmedizin Berlin), Gerd Geißlinger(Goethe University Frankfurt), Julien Hanson(University of Liège), Marc Peters‐Golden(Michigan Medicine), Karsten H. Weylandt(University of Applied Sciences Potsdam), Stefan Offermanns(Max Planck Institute for Heart and Lung Research), Astrid S. Kahnt(Goethe University Frankfurt), Per‐Johan Jakobsson(Karolinska University Hospital), Garret A. FitzGerald(California University of Pennsylvania)
Cited by 187
Related Papers
Prostaglandins and Inflammation
|Arteriosclerosis Thrombosis and Vascular Biology|2011|3.7k
The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition
|Proceedings of the National Academy of Sciences|2014|2.1k
A comprehensive classification system for lipids
|Journal of Lipid Research|2005|1.8k
Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin
|New England Journal of Medicine|2001|1.4k
LMSD: LIPID MAPS structure database
|Nucleic Acids Research|2006|1.4k